Application 217180

Type
NDA
Sponsor
INCYTE CORP

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001JAKAFI XRRUXOLITINIB PHOSPHATETABLET, EXTENDED RELEASE;ORALEQ 11MG BASEYesNo
002JAKAFI XRRUXOLITINIB PHOSPHATETABLET, EXTENDED RELEASE;ORALEQ 22MG BASEYesNo
003JAKAFI XRRUXOLITINIB PHOSPHATETABLET, EXTENDED RELEASE;ORALEQ 33MG BASEYesNo
004JAKAFI XRRUXOLITINIB PHOSPHATETABLET, EXTENDED RELEASE;ORALEQ 44MG BASEYesNo
005JAKAFI XRRUXOLITINIB PHOSPHATETABLET, EXTENDED RELEASE;ORALEQ 55MG BASEYesYes

Documents

DocumentSubmission typeDate
85837ORIG 2026-05-05
85824ORIG 2026-05-04